The MDM2 -309 T/G promoter single nucleotide polymorphism does not alter disease characteristics in chronic lymphocytic leukemia

T. Zenz, S. Habe, A. Benner, D. Kienle, H. Dohner, S. Stilgenbauer
2008 Haematologica  
Letters to the Editor haematologica | 2008; 93(7) | 1111 | years who require therapy. This finding supports the clinical significance of the genetic background of the IL6 pathway in WM.
doi:10.3324/haematol.12738 pmid:18508789 fatcat:uxbtkum6bfgonjdo2xaj2twbre